Immune hemolysis-serological and clinical aspects

Area of Science:

• Hematology
• Immunology
• Clinical Diagnostics

Background:

• Immune hemolytic anemias are a frequent cause of anemia requiring differential diagnosis.
• Routine serology detects anti-red blood cell (RBC) alloantibodies, but autoimmune and drug-induced hemolytic anemias pose diagnostic challenges.
• The direct antiglobulin test (Coombs' test) is crucial for diagnosing immune hemolytic anemias.

Purpose of the Study:

• To review the biochemical aspects, diagnostic approaches, and clinical significance of RBC allo- and autoantibodies.
• To summarize current and experimental therapeutic strategies for immune hemolytic anemias.
• To highlight the complexities in diagnosing autoimmune and drug-induced hemolytic anemias.

Main Methods:

• Review of literature on immune hemolytic anemias, focusing on diagnostics and therapeutics.
• Discussion of immunohematological diagnostic techniques, including the direct antiglobulin test.
• Analysis of biochemical factors and clinical relevance of RBC antibodies.

Main Results:

• Accurate diagnosis of immune hemolytic anemias often requires multidisciplinary collaboration.
• Acute intravascular hemolysis following ABO incompatible RBC transfusion is a severe manifestation.
• RBC allo- and autoantibodies, paroxysmal nocturnal hemoglobinemia, and drug-induced hemolysis are key areas of focus.

Conclusions:

• Effective management of immune hemolytic anemias relies on accurate immunohematological diagnostics.
• Understanding RBC antibody mechanisms is vital for clinical decision-making.
• Therapeutic strategies are evolving, with ongoing research into novel treatments.